These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18327682)

  • 21. Mucocutaneous leishmaniasis: report of a case with massive involvement of nasal, pharyngeal and laryngeal mucosa.
    Di Lella F; Vincenti V; Zennaro D; Afeltra A; Baldi A; Giordano D; Pasanisi E; Bacciu A; Bacciu S; Di Lella G
    Int J Oral Maxillofac Surg; 2006 Sep; 35(9):870-2. PubMed ID: 16574379
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of parasitic diarrhea in HIV-infected patients.
    Derouin F; Lagrange-Xelot M
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):337-49. PubMed ID: 18588498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of intestinal protozoan infections in children.
    Escobedo AA; Almirall P; Alfonso M; Cimerman S; Rey S; Terry SL
    Arch Dis Child; 2009 Jun; 94(6):478-82. PubMed ID: 19329448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tropical diseases -- leishmaniasis].
    Z Gastroenterol; 2013 Aug; 51(8):720. PubMed ID: 24298631
    [No Abstract]   [Full Text] [Related]  

  • 26. Duodenal leishmaniasis after allogeneic hematopoietic SCT.
    Martínez-Losada C; Martin C; Cuenca T; Torres A
    Bone Marrow Transplant; 2013 Apr; 48(4):614-5. PubMed ID: 23042493
    [No Abstract]   [Full Text] [Related]  

  • 27. Leishmaniasis in the tongue of an immunocompetent man.
    Leitner V; Weingast J; Harmankaya K; Walochnik J; Pehamberger H; Petzelbauer P; Auer H; Binder M
    Am J Trop Med Hyg; 2010 Apr; 82(4):597-9. PubMed ID: 20348506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intestinal parasites here and elsewhere].
    Chappuis F; Gétaz L
    Rev Med Suisse; 2011 Jan; 7(279):200, 202. PubMed ID: 21387712
    [No Abstract]   [Full Text] [Related]  

  • 29. Leishmaniasis and other dermatozoonoses in Brazil.
    Ramos-E-Silva M; De Moura Castro Jacques C
    Clin Dermatol; 2002; 20(2):122-34. PubMed ID: 11973046
    [No Abstract]   [Full Text] [Related]  

  • 30. Foamy histiocytes in a patient with visceral leishmaniasis after treatment with liposomal amphotericin B.
    Tavil B; Seçmeer G; Ozen H; Cengiz AB; Unal S; Gürgey A
    Turk J Pediatr; 2008; 50(1):67-9. PubMed ID: 18365595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran.
    Alborzi A; Pouladfar GR; Fakhar M; Motazedian MH; Hatam GR; Kadivar MR
    Am J Trop Med Hyg; 2008 Sep; 79(3):435-7. PubMed ID: 18784238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.
    Manfredi R; Marinacci G; Calza L; Passarini B
    Int J Antimicrob Agents; 2008 Jun; 31(6):590-2. PubMed ID: 18456464
    [No Abstract]   [Full Text] [Related]  

  • 33. Cutaneous leishmaniasis with boggy induration and simultaneous mucosal disease.
    Mings S; Beck JC; Davidson C; Ondo AL; Shanler SD; Berman J
    Am J Trop Med Hyg; 2009 Jan; 80(1):3-5. PubMed ID: 19141829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cutaneous leishmaniasis].
    Nicolay M; Bourlond-Reinert L
    Arch Belg Dermatol; 1973; 29(4):327-31. PubMed ID: 4802173
    [No Abstract]   [Full Text] [Related]  

  • 35. Targets for immunochemotherapy in leishmaniasis.
    Mukhopadhyay D; Saha P; Chatterjee M
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):261-4. PubMed ID: 22397558
    [No Abstract]   [Full Text] [Related]  

  • 36. Comment on: Unresponsiveness to AmBisome in some Sudanese patients with kala-azar.
    de Górgolas M
    Trans R Soc Trop Med Hyg; 2007 Oct; 101(10):1054; author reply 1054-5. PubMed ID: 17651771
    [No Abstract]   [Full Text] [Related]  

  • 37. Liposomal Amphotericin B Treatment and the Leishmaniases.
    Berman J
    Am J Trop Med Hyg; 2019 Oct; 101(4):727-728. PubMed ID: 31482790
    [No Abstract]   [Full Text] [Related]  

  • 38. Diffuse cutaneous leishmaniasis in Ethiopia. II. Treatment.
    Bryceson AD
    Trans R Soc Trop Med Hyg; 1970; 64(3):369-79. PubMed ID: 5453496
    [No Abstract]   [Full Text] [Related]  

  • 39. Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient.
    Ramos A; Cruz I; Muñez E; Salas C; Fernández A; Alvarez-Espejo T
    Infection; 2008 Mar; 36(2):184-6. PubMed ID: 18327683
    [No Abstract]   [Full Text] [Related]  

  • 40. [Control of parasites in the digestive tract of children in rural areas].
    Kurdziel Z
    Pediatr Pol; 1968 Sep; 43(9):1143-7. PubMed ID: 5708454
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.